Skip to main content Accessibility help
×
Home
  • Print publication year: 2006
  • Online publication date: February 2010

12 - Post partum hemorrhage: Prevention, diagnosis, and management

    • By William F. Baker, Associate Clinical Professor of Medicine Center for Health Sciences, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, USA, Thrombosis, Hemostasis and Special Hematology, Clinic, Kern Medical Center, Bakersfield, California, Joseph Mansour, Associate Professor Department of Obstetrics and Gynecology, Kern Medical Center, Bakersfield, California, USA, Arthur Fontaine, Chairman of Radiology, Mercy Hospital, Bakersfield, California, USA
  • Edited by Rodger L. Bick, University of Texas Southwestern Medical Center, Dallas, Eugene P. Frenkel, University of Texas Southwestern Medical Center, Dallas, William F. Baker, University of California, Los Angeles, Ravi Sarode, University of Texas Southwestern Medical Center, Dallas
  • Publisher: Cambridge University Press
  • DOI: https://doi.org/10.1017/CBO9780511526978.013
  • pp 361-441

Summary

Introduction

Although childbirth is a wonderful and enjoyable experience by most, it still is an anatomically traumatic event, associated with tissue injury, vascular disruption and the potential for blood loss. All deliveries are accompanied by physiologic hemorrhage from the genital tract, and the abdominal soft tissue in cesarean section (Table 12.1). Post partum hemorrhage (PPH) is an obstetrical complication, which can transform a normal physiologic process of labor and delivery into a life-threatening emergency within minutes. A routine cesarean section can be complicated by massive hemorrhage. The healthy mother may quickly become a patient in the critical care unit, requiring all of the available skill and resources of physicians, nurses, the medical laboratory and the blood bank for survival. A thorough knowledge of the risk factors, preventive strategies, approach to diagnosis and management of PPH are required to properly care for women presenting for delivery. Once PPH is diagnosed, hospital facilities and/or referral centers, laboratories and blood banks must be readily available to provide the optimal chance for a successful outcome. The availability of blood replacement and modern critical care are major determinants of survival in women who develop post partum hemorrhagic shock. Mortality from PPH is strongly correlated with substandard care. Clearly, it is the problem of PPH that most vividly illustrates the difference, worldwide, between management of the puerperium in developed countries from that in underdeveloped countries.

REFERENCES
The Department of Health. Why Mothers Die. Report on confidential enquiries into maternal deaths in the United Kingdom 1994/96. London: HMSO; 1998.
Etuk, S. J., Asuquo, E. E.Effects of community and health facility interventions on postpartum hemorrhage. Int. J. Gynaecol. Obstet., 2000; 70(3): 381–3.
WHO. Preventing Maternal Deaths. Geneva: WHO; 1989.
Abou, Zahr C. R. E.Maternal Mortality: A Global Factbook. Geneva: World Health Organization; 1991.
Mousa, H. A., Walkinshaw, S.Major postpartum haemorrhage. Curr. Opin. Obstet. Gynecol., 2001; 13(6): 595–603.
Kraunitz, A., Hughs, J., Grimes, D., et al. Causes of maternal mortality in the United States. Obstet. Gynecol., 1985; 65: 605–12.
Chichakli, L. O., Atrash, H. K., MacKay, A. P., et al. Pregnancy-related mortality in the United States due to hemorrhage: 1979–1992. Obstet. Gynecol., 1999; 94(5 Pt 1): 721–5.
Combs, C. A., Murphy, E. L., Laros, R. K. JrFactors associated with postpartum hemorrhage with vaginal birth. Obstet. Gynecol., 1991; 77: 69–76.
Combs, C. A., Murphy, E. L., Laros, R. K. JrFactors associated with hemorrhage in cesarean deliveries. Obstet. Gynecol., 1991; 77: 77–82.
Pahlavan, P., Nezhat, C.Hemorrhage in obstetrics and gynecology. Curr. Opin. Obstet. Gynecol., 2001; 13(4): 419–24.
Prendiville, W., Elbourne, D., Chalmers, I.The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. Br. J. Obstet. Gynaecol., 1988; 95: 3–16.
Prendiville, W., Harding, J. E., Elbourne, D., et al. The Bristol third stage trial: active versus physiological management of third stage of labour. BMJ, 1988; 297: 1295–300.
Etuk, S. J., Itam, I. H., Asuquo, E. E.Morbidity and mortality in booked women who deliver outside orthodox health facilities in Calabar, Nigeria. Acta Trop., 2000; 75(3): 309–13.
Bonnar, J.Massive obstetric haemorrhage. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol., 2000; 14(1): 1–18.
Gerstenfeld, T. S., Wing, D. A.Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery. Am. J. Obstet. Gynecol., 2001; 185(4): 878–82.
WHO. The Prevention and Management of Post Partum Haemorrhage. Report of a technical working group. Geneva: WHO; 1990.
Higgins, S.Obstetric haemorrhage. Emerg. Med., (Fremantle), 2003; 15(3): 227–31.
Pritchard, J. A., Baldwin, R. M., Dickey, J. C., et al. Blood volume changes in pregnancy and the puerperium. II. Red blood cell loss and changes in apparent blood volume during and following vaginal delivery, cesarean section, and cesarean section plus total hysterectomy. Obstet. Gynecol., 1962; 84: 1271–82.
El-Refaey, H., Rodeck, C.Post-partum haemorrhage: definitions, medical and surgical management. A time for change. Br. Med. Bull., 2003; 67: 205–17.
McCormick, M. L., Sanghvi, H. C., Kinzie, B., et al. Preventing postpartum hemorrhage in low-resource settings. Int. J. Gynaecol. Obstet., 2002; 77(3): 267–75.
Sharma, S., El-Refaey, H.Prostaglandins in the prevention and management of postpartum haemorrhage. Best Pract. Res. Clin. Obstet. Gynaecol., 2003; 17(5): 811–23.
Waterstone, M., Bewley, S., Wolfe, C.Incidence and predictors of severe obstetric morbidity: case-control study. BMJ, 2001; 322(7294): 1089–93; discussion, 93–4.
Rangel-Frausto, M. S., Pittet, D., Costignan, M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA, 1995; 273: 117–23.
Bone, R. S.Toward a theory of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit. Care Med., 1996; 24: 163–72.
Shyu, K. G., Chang, H., Linn, C. C., et al. Concentrations of serum interleukin-8 after successful cardiopulmonary resuscitation in patients with cardiopulmonary arrest. Am. Heart. J., 1997; 134: 551–6.
Geppert, A., Zorn, G., Karth, G. D., et al. Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Crit. Care Med., 2000; 28: 2360–5.
Levi, M., Jonge, E., Poll, T., et al. Disseminated intravascular coagulation. Semin. Thromb. Hemost., 1999; 82: 695–705.
Gando, S.Disseminated intravascular coagulation in trauma patients. Semin. Thromb. Hemost., 2001; 27(6): 585–92.
Mammen, E. F., Anderson, G. F., Barnard, M. I.Disseminated intravascular coagulation in man. Thromb. Diath. Haemorrh., 1969; 36(Suppl.): 171–6.
Garcia-Fernandez, N., Montes, R., Purroy, A., et al. Hemostatic disturbances with systemic inflammatory response syndrome (SIRS) and associated acute renal failure (ARF). Thromb. Res., 2000; 100: 19–25.
Roumen, R. M., Hendricks, T., et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann. Surg., 1993; 218: 769–76.
Schrager, S., Sabo, L.Sheehan syndrome: a rare complication of postpartum hemorrhage. J. Am. Board Fam. Pract., 2001; 14(5): 389–91.
Karpati, P. C., Rossignol, M., Pirot, M., et al. High incidence of myocardial ischemia during postpartum hemorrhage. Anesthesiology 2004; 100(1): 30–6; discussion, 5 A.
Levi, M., ten Cate, H.Disseminated intravascular coagulation. N. Engl. J. Med., 1999; 341: 586–92.
Gynecologists ACoOa. Hemorrhagic shock. Int. J. Gynaecol. Obstet., 1997; 57: 219–26.
Phillips, T. F., Soulier, G., Wilson, R. F.Outcome of massive transfusion exceeding two blood volumes in trauma and emergency surgery. J. Tramua, 1987; 27: 903–10.
Smith, H. O., Romero, A. Shock in the gynecologic patient. In Rock, J. A., Jones, H. W. III, eds., Te Linde's Operative Gynecology. Philadelphia, PA: Lippincott, Williams and Wilkins; 2003: pp. 209–32.
Gando, S., Satoshi, N., Osamu, K.Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: Application of clinical decision analysis. Ann. Surg., 1999; 229: 1–15.
Lipitz, S., Admon, D., Menczer, J., et al. Midtrimester bleeding: Variables which affect the outcome of pregnancy. Gynecol. Obstet. Invest., 1991; 32: 24.
Ajayi, R. A., Soothill, P. W., Campbell, S., et al. Antenatal testing to predict outcome in pregnancies with unexpected antepartum haemorrhage. Br. J. Obstet. Gynaecol., 1992; 99: 122.
Cunningham, F. C., Gant, N. F., Leveno, K. J., eds. Williams Obstetrics. 21st edn. New York, NY: McGraw-Hill; 2001.
Farine, D., Fox, H. E., Jackobson, S., et al. Vaginal ultrasound for diagnosis of placenta previa. Am. J. Obstet. Gynecol., 1988; 159: 566.
Hertzberg, B. S., Bowie, J. D., Carroll, B. A., et al. Diagnosis of placenta previa during the third trimester: Role of transperineal sonography. Am. J. Roentgenol., 1992; 159: 83.
Smith, R. S., Lauria, M. R., Comstock, C. H., et al. Transvaginal ultrasonography for all placentas that appear to be low-lying or over the internal cervical os. Ultrasound Obstet. Gynecol., 1997; 9: 22.
Wald, D. A.Postpartum hemorrhage resulting from uterine artery pseudoaneurysm. J. Emerg. Med., 2003; 25(1): 57–60.
Davidsen, M. B., Madsen, P. V., Wilken-Jensen, C.True aneurysm of the uterine artery. Eur. J. Surg., 1995; 161: 775–6.
Clark, S. L., Koomings, P. P., Phelan, J. P.Placenta previa/accreta and previous cesarean section. Obstet. Gynecol., 1985; 66: 89–92.
Chesley, L. C.Plasma and red cell volumes during pregnancy. Am. J. Obstet. Gynecol., 1972; 112: 440–50.
Dildy, G. A., 3rd. Postpartum hemorrhage: new management options. Clin. Obstet. Gynecol., 2002; 45(2): 330–44.
Bletka, M., Hlavaty, V., Trnkova, M., et al. Volume of whole blood and absolute amount of serum proteins in the early stage of late toxemia of pregnancy. Am. J. Obstet. Gynecol., 1970; 106: 10–13.
Nizzi, F., Mues, G.Hemorrhagic problems in obstetrics, exclusive of disseminated intravascular coagulation. Hem./Onc. Clinics North Am., 2000; 14: 1171–82.
Khan, R., Sharma, S.Use of misoprostol in third stage of labour. Lancet, 2002; 359(9307): 708–9; author reply, 9–10.
Kadir, R. A., Economides, D. L., Sabin, C., et al. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet, 1998; 351: 485–9.
Schuurmans, N., Mac Kinnon, C., Lane, C., et al. Prevention and management of postpartum haemorrhage. J. Soc. Obstet. Gynaecol. Can., 2000; 22: 271–81.
Thomas, J. M.The treatment of obstetric haemorrhage in women who refuse blood transfusion. Ltr. Br. J. Obstet. Gynaecol., 1998; 105: 127–8.
Baker, W. F. JrIron deficiency in pregnancy, obstetrics and gynecology. Hem./Onc. Clinics North Am., 2000; 14: 1061–77.
Deering, S. H., Landy, H. J., Tchado, N., et al. Hypodysfibrinogenemia during pregnancy, labor, and delivery. Obstet. Gynecol., 2003; 101: 1092–4.
Roque, H., Stephenson, M., Lee, M. J., et al. Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies. Am. J. Hematol., 2004; 76: 267–70.
Nizzi, F., Sapatnekar, S., Bick, R. L. Hereditary coagulation protein defects. In Bick, R. L., ed. Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice. Third edn. Philadelphia, PA: Lippincott, Williams and Wilkins; 2002: pp. 117–37.
Kobayashi, T., Kanayama, N., Tokunaga, N., et al. Prenatal and peripartum management of congenital afibrinogenemia. Br. J. Haematol., 2000; 109: 364–6.
Parameswaran, R., Dickinson, J., DeLord, S., et al. Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapy. Haemophilia, 2000; 6: 705–8.
Schroeder, M. L. Principles and practice of transfusion medicine. In Lee, G. R., Foerster, J., Lukens, J., et al. eds., Wintrobe's Clinical Hematology. 10th edn. Baltimore: Lippincott, Williams and Wilkins; 1999: pp. 817–74.
Roberts, H. R., White, G. C. Inherited disorders of prothrombin conversion. In Colman, R. W., Hirsh, J., Marder, V. I., et al. eds., Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott, Williams and Wilkins; 2001: pp. 839–53.
Rodgers, G. M., Greenberg, G. S. Inherited coagulation disorders. In Lee, G. R., Foerster, J., Lukens, J., et al. eds. Wintrobe's Clinical Hematology. Baltimore, MD: Lippincott, Williams and Wilkins; 1999: p. 1682.
Rogers, G. M., Greenberg, C. S. Inherited coagulation disorders. In Lee, G. R., Foerster, J., Paraskevas, F., et al. eds. Wintrobe's Clinical Hematology. Baltimore, MD: Lippincott, Williams and Wilkins; 1999: pp. 1682–732.
Bick, R. L. Platelet-function defects. In Bick, R. L., ed., Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice. Philadelphia, PA: Lippincott, Williams and Wilkins; 2002: pp. 59–90.
Eskandari, N., Feldman, N., Greenspoon, J. S.Factor VII deficiency in pregnancy treated with recombinant factor VIIa. Obstet. Gynecol., 2002; 99: 935–7.
Fadel, H. E., Krauss, J. S.Factor VII deficiency and pregnancy. Obstet. Gynecol., 1989; 73: 453–4.
Bauer, K.Treatment of factor VIIa deficiency with recombinant factor VII. Haemostasis, 1996; 26(Suppl. 1): 155–8.
Jimenez-Yuste, V., Villar, A., Morado, M., et al. Continuous infusion of recombinant activated factor VII during cesarean section delivery in a patient with congenital factor VII deficiency. Haemophilia, 2000; 6: 588–90.
Arun, B, Kessler, C. M. Clinical manifestations and therapy of the hemophilias. In Colman, R. W., Hirsh, J., Marder, V. I., et al. eds., Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott Williams and Wilkins; 2001: pp. 815–24.
Hay, C. R., Negrier, C., Ludlam, C. A.The treatment of bleeding in acquired hemophilia with recombinant factor VIIa: a multicentre study. Thromb. Haemost., 1997; 78: 1463–7.
Green, D., Lechner, K.A survey of 215 nonhemophilic patients with inhibitors to factor VIII. Thromb. Haemost., 1981; 45: 200.
Michiels, J. J.Acquired hemophilia A in women postpartum: clinical manifestations, diagnosis and treatment. Clin. Appl. Thromb. Hemost., 2000; 6: 82–6.
Dhar, P., Abramovitz, S., DiMichele, D. M., et al. Management of pregnancy in a patient with severe hemophilia A. Br. J. Anaesth., 2003; 91: 432–5.
DiMichele, D. M., Green, D. Hemophilia-factor VIII deficiency. In Locscalzo, J., Schafer, A. I., eds., Thrombosis and Hemorrhage. Baltimore, MD: Williams and Wilkins; 1998: pp. 757–72.
Pejsa, V., Grgurevic, I., Kusec, R., et al. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia. Croat. Med. J., 2004; 45: 213–16.
Bockenstedt, P. L. Laboratory methods in hemostasis. In Loscalzo, J., Schafer, A. I., eds., Thrombosis and Hemorrhage. Baltimore: Williams and Wilkins; 1998: pp. 517–80.
Grosset, A. B., Rodgers, G. Acquired coagulation disorders. In , J. W. P, ed., Wintrobe's Clinical Hematology. Baltimore, MD; 1999: pp. 1733–80.
Pineda, A. A. Indications for hemapheresis procedures in hematologic disorders. In Bick, R. L., ed., Hematology: Clinical and Laboratory Practice. St. Louis,; 1993: 1681–9.
Arkel, Y. S., Ku, D. W. Acquired blood coagulation inhibitors. In Bick, R. L., ed., Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice. 3rd edn. Philadelphia, PA: Lippincott, Williams and Wilkins; 2002: pp. 213–49.
Greenberg, C. S., Orthner, C. Blood coagulation and fibrinolysis. In Pine, J. W., ed., Wintrobe's Clinical Hematology. Baltimore, MD: LWW; 1999: pp. 684–764.
Roberts, N. S., Bingham, M. D. Other coagulation factor deficiencies. In Loscalzo, J., Schafer, A. I., eds., Thrombosis and Hemorrhage. Baltimore, MD: Williams and Wilkins; 1998: 773–802.
Ozsoylu, S., Ozer, F. L.Acquired factor IX deficiency. Acta Haematol., 1973; 50: 305–14.
Green, D. Factor VIII and other coagulation factor inhibitors. In Loscalzo, J., Schafer, A. I., eds., Thrombosis and Hemorrhage. Baltimore, MD: Williams and Wilkins; 1998: pp. 803–15.
Romagnolo, C., Burati, S., Ciaffoni, S., et al. Severe factor X deficiency in pregnancy: case report and review of the literature. Haemophilia, 2004; 10: 665–8.
David, A. L., Paterson-Brown, S., Letsky, E. A.Factor XI deficiency presenting in pregnancy: diagnosis and management. Br. J. Obstet. Gynaecol., 2002; 109(7): 840–3.
Loewy, A. G., McDonagh, J., Mikkola, H., et al. Structure and function of factor XIII. In Colman, R. W., Hirsh, J., Marder, V. I., et al. eds., Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott, Williams and Wilkins; 2001: pp. 233–47.
Nichols, W. C., Cooney, K. A., Ginsburg, D., et al. Von Willebrand disease. In Loscalzo, J., Schafer, A. I., eds., Thrombosis and Hemorrhage. Baltimore, MD: Williams and Wilkins; 1998: pp. 729–55.
Lak, M., Peyvandi, F., Mannucci, P. M.Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br. J. Haematol., 2000; 111(4): 1236–9.
Ramsahoye, B. H., Davies, S. V., Dasani, H.Management of pregnancy and delivery in von Willebrand's disease. Blood, 1993; 82(Suppl. 1): 150.
Roque, H., Funai, E., Lockwood, C. J.Von Willebrand disease and pregnancy. J. Matern. Fetal Med., 2000; 9(5): 257–66.
Sadler, J. E., Blinder, M. Von Willebrand disease: Diagnosis, classification and treatment. In Colman, R. W., Hirsh, J., Marder, V. I., et al. eds., Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott, Williams and Wilkins; 2001: pp. 826–37.
Oshiro, B. T., Branch, W. Maternal hemostasis: coagulation problems in pregnancy. In Loscalzo, J., Schafer, A. I., eds., Thrombosis and Hemorrhage. Baltimore, MD: Williams and Wilkins; 1998: pp. 1005–26.
Thilaganathan, B., Cutner, A., Latimer, J., et al. Management of the third stage of labor in women at low risk of postpartum hemorrhage. Eur. J. Obstet. Gynecol. Reprod. Biol., 1993; 48: 19.
Midwives ICo, Obstetricians IFoGa. Joint Statement: Management of the third stage of labour to prevent post-partum haemorrhage. J. Midwifery Womens Health 2004; 49: 76–7.
Prendiville, W. J., Elbourne, D., McDonald, S.Active versus expectant management in the third stage of labour. Cochrane Database Syst. Rev., 2000; 3: CD000007.
Nordstrom, L., Fogelstam, K., Fridman, G., et al. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br. J. Obstet. Gynaecol., 1997; 104: 781–6.
Noort, W. A., Bulck, B., Vereecken, A., et al. Changes in plasma levels of PGF2 alpha and PGI2 metabolites at and after delivery at term. Obstet. Gynecol., 1989; 37: 3–12.
Thornton, S., Davison, J. M., Baylis, P. H.Plasma oxytocin during third stage of labour: comparison of natural and active management. BMJ, 1988; 297: 167–9.
Jackson, K. W. Jr., Allbert, J. R., Schemmer, G. K., et al. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am. J. Obstet. Gynecol., 2001; 185(4): 873–7.
Hendricks, C. H., Brenner, W. E.Cardiovascular effects of oxytocic drugs used post partum. Am. J. Obstet. Gynecol., 1970; 108: 751.
Choy, C. M., Lau, W. C., Tam, W. H., et al. A randomised controlled trial of intramuscular syntometrine and intravenous oxytocin in the management of the third stage of labour. Br. J. Obstet. Gynaecol., 2002; 109(2): 173–7.
Darney, P. D.Misoprostol: a boon to safe motherhood … or not? Lancet, 2001; 358(9283): 682–3.
Bugalho, A., Daniel, A., Faundes, A., et al. Misoprostol for prevention of postpartum hemorrhage. Int. J. Gynaecol. Obstet., 2001; 73(1): 1–6.
Lokugamage, A. U., Sullivan, K. R., Niculescu, I., et al. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage. Acta Obstet. Gynecol. Scand., 2001; 80(9): 835–9.
Gulmezoglu, A. M., Villar, J., Ngoc, N. T., et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet, 2001; 358(9283): 689–95.
Goldberg, A. B., Greenberg, M. B., Darney, P. D.Misoprostol and pregnancy. N. Engl. J. Med., 2001; 344(1): 38–47.
Dumoulin, J. G.A reappraisal of the use of ergometrine. J. Obstet. Gynaecol., 1981; 1: 178–81.
Carey, M.Adverse cardiovascular sequelae of ergometrine. Br. J. Obstet. Gynaecol., 1981; 100: 865.
Abdel-Aleem, H., El-Nashar, I., Abdel-Aleem, A.Management of severe postpartum hemorrhage with misoprostol. Int. J. Gynaecol. Obstet., 2001; 72(1): 75–6.
Rolfes, D. B., Ishak, K. G.Liver disease in toxemia of pregnancy. Am. J. Gastroenterol., 1986; 81: 1138.
Sheikh, R. A., Yasmeen, S., Pauly, M. P., et al. Spontaneous intrahepatic hemorrhage and rupture in the HELLP syndrome: four cases and a review. J. Clin. Gastroenterol., 1999; 28: 323.
Stain, S. C., Woodburn, D. A., Stephens, A. L., et al. Spontaneous hepatic hemorrhage associated with pregnancy. Treatment with hepatic arterial ligation. Ann. Surg., 1996; 224: 72.
Smith, L. G., Moise, K. J. Jr, Dildy, G. A. III, et al. Spontaneous rupture of liver during pregnancy: Current therapy. Obstet. Gynecol., 1991; 77: 171.
Davies, S.Amniotic fluid embolism: a review of the literature. Can. J. Anaesth., 2001; 48: 88–98.
Locksmith, G. J.Amniotic flud embolism. Obstet. Gynecol. Clin. North. Am., 1999; 26: 435–44.
Martel, M., MacKinnon, C. J., Arsenault, M., et al. Hemorrhagic shock. J. Obstet. Gynaecol. Can., 2002; 24: 504–11.
Smith, H. O. Shock in the gynecologic patient. In Rock, J. A., Thomson, J. D., eds., Te Linde's Operative Gynecology, 8th edn. Philadelphia, PA: Lippincott-Raven; 1997: pp. 245–61.
Falk, J. L., O'Brien, J. F., Kerr, R.Fluid resuscitation in traumatic hemorrhagic shock. Crit. Cre. Clin., 1992; 8: 323–40.
Assali, N. S.Dynamics of the uteroplacental circulation in health and disease. Am. J. Perinatol., 1989; 6: 105–9.
Marzi, I.Hemorrhagic shock: update in pathophysiology and therapy. Acta Anaesthesiol. Scand. Suppl., 1997; 111: 42–4.
Bick, R. L.Disseminated intravascular coagulation. Hematol. Oncol. Clin. North Am., 1992; 6(6): 1259–85.
Davies, S.Amniotic fluid embolism and isolated disseminated intravascular coagulation. Can. J. Anaesth., 1999; 46(5 Pt 1): 456–9.
Clark, S. L.New concepts of amniotic fluid embolism: a review. Obstet. Gynecol. Surv., 1990; 45: 360–8.
Clark, S. L., Hankins, G. D V, Dudley, D. A., et al. Amniotic fluid embolism: analysis of the national registry. Am. J. Obstet. Gynecol., 1995; 172: 1158–69.
Morgan, M.Amniotic fluid embolism. Anaesthesia, 1979; 34: 20–32.
Bland, R. D., Shoemaker, W. C., Abraham, E., et al. Hemodynamic and oxygen transport patterns in surviving and nonsurviving postoperative patients. Crit. Care Med., 1985; 13: 85–95.
Chiao, J., Minei, J. P., Shires, G. T.In vivo myocyte sodium activity and concentration during hemorrhagic shock. Am. J. Physiol., 1990; 258: R864.
Isbister, J. P.Physiology and pathophysiology of blood volume regulation. Transus. Sci., 1997; 18: 409–23.
Barber, A., Shires III, G. T., Shires, G. T. Shock. In Schwartz, S. I., Shires, G. T., Spencer, F. C., et al. eds., Principles of Surgery, 7th edn. New York, NY: McGraw-Hill; 1999: p. 101.
Bitterman, H., Smith, B. A., Lefer, A. M.Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock. Circ. Shock, 1988; 24: 159.
Hierholzer, C., Billiar, T. R.Molecular mechanisms in the early phase of hemorrhagic shock. Langenbeck's Arch. Surg., 2001; 386: 302–8.
Afessa, B., Green, B., Delke, I., et al. Systemic inflammatory response syndrome, organ failure, and outcome in critically ill obstetric patients treated in an ICU. Chest, 2001; 120: 1271–7.
Tamian, F., Richard, V., Bonmarchand, G., et al. Induction of hemo-oxygenase-1 prevents the systemic reponses to hemorrhagic shock. Am. J. Respir. Crit. Care Med., 2001; 164: 1933–8.
Muckart, D. J., Bhagwanjee, S.American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit. Care Med., 1997; 25: 1789–95.
Shoemaker, W. C., Peitzman, A. B., Bellamy, R., et al. Resuscitation from severe hemorrhage. Crit. Care Med., 1996; 24(2 Suppl.)(S 12–23).
Cavanagh, D., Mardsen, D. E.Hemorrhagic shock in the gynecologic patient. Clin. Obstet. Gynecol., 1985; 28: 383.
Shiers, G. T., Barber, A. E., Illner, H. P.Current status of resuscitation: solutions including hypertonic saline. Adv. Surg., 1995; 28: 133–70.
Bickell, W. H., Wall, M. J. Jr, Pepe, P. E., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N. Engl. J. Med., 1994; 331: 1105–9.
Schierhout, G., Roberts, I.Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ, 1998; 316: 961–4.
Bunn, F., Lefebvre, C., Li-Wan-Po, A., et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst. Rev., 2000; 2: CD001208.
Gould, S. A., Sehgal, L. R., Sehgal, H. L., et al. Hypovolemic shock. Crit. Care Clin., 1993; 9: 239–59.
Mousa, H. A., Alfirevic, Z.Treatment for primary postpartum haemorrhage. Cochrane Database Syst. Rev., 2003; 1: CD003249.
Lucas, C. E.Update on trauma care in Canada. 4. Resuscitation through the three phases of hemorrhagic shock after trauma. Can. J. Surg., 1990; 33: 451–6.
Macphail, S. F. J.Massive post-partum hemorrhage. Curr. Opin. Obstet. Gynaecol., 2001; 11: 108–14.
Nolan, T. E., Gallup, D. G.Massive transfusion: a current review. Obstet. Gynecol. Surv., 1991; 46(5): 289–95.
Petz, L. D.Red blood cell transfusion. Clin. Oncol., 1983; 2: 505.
Gynecologists ACoOa. Blood component therapy. Int. J. Gynaecol. Obstet., 1995; 48: 233–8.
Wilson, R. F. Trauma. In Shoemaker, W. C., Thompson, W. L., Holbrook, P. R., eds., Textbook of Critical Care. Philadelphia, PA: W. B. Saunders Co.; 1984: pp. 877–914.
Hewitt, P. E., Machin, S. J. Massive blood transfusion. In ABC of Transfusion. London: BMJ Publishing Group; 1998: pp. 49–52.
Hiippala, S.Replacement of massive blood loss. Vox Sang, 1998; 74 (Suppl. 2): 399–407.
Elder, P. T. Accidental hypothermia. In Shoemaker, W. C., Thompson, W. L., Holbrook, P. R., eds., Textbook of Critical Care. Philadelphia, PA: W. B. Saunders Co.; 1984: pp. 85–93.
Mahajan, W. I., Meyers, T. J., Baldini, M. G.Disseminated intravascular coagulation during rewarming following hypothermia. JAMA, 1981; 245: 2517.
Valeri, C. R., Cassidy, G., Khuri, S., et al. Hypothermia-induced reversible platelet dysfunction. Ann. Surg., 1987; 205: 175–81.
Luna, G. K., Maier, R. V., Pavlin, E. G., et al. Incidence and effect of hypothermia in seriously injured patietns. J. Trauma, 1987; 27: 1014–18.
Carmichael, D., Hosty, T., Kastl, D., et al. Hypokalemia and massive transfusion. South Med. J., 1984; 77: 315–17.
Durand, F., Duchesne-Gueguen, M., Bervet, J. Y., et al. Rheologic and cytologic study of autologous blood collected with Cell Saver 4 during cesarean. Rev. Fr. Transfus. Hemobiol., 1989; 32: 179–91.
Zichella, L., Gramolini, R.Autotransfusion during cesarean section. Am. J. Obstet. Gynecol., 1990; 162: 295.
Bernstein, H. H., Rosenblatt, M. A., Gettes, M., et al. The ability of haemonetics 4 Cell Saver system to remove tissue factor from blood contaminated with amniotic fluid. Anesth. Analg., 1997; 85: 831–3.
Rebarber, A., Lonser, R., Jackson, S., et al. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am. J. Obstet. Gynecol., 1998; 179 (3 Pt 1): 715–20.
Hocker, P., Hartmann, T.Management of massive transfusion. Acta Anaesthesiol. Scand. Suppl., 1997; 111: 205–7.
Harigan, C., Lucas, C. E., Ledgerwood, A. M.The effect of hemorrhagic shock on the clotting cascade in injured patients. J. Trauma, 1989; 29(10): 1416–21.
Pathologists DTFotCoA. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets: fresh frozen plasma, cryoprecipitate and platelets administraton practice guideline. JAMA, 1994; 24: 777–8.
Health NIo. Fresh frozen plasma: Indications and risks. In Consensus Development Conference; 1985: JAMA, 1985; 253: 551–3.
Lundsgard-Hansen, P.Component therapy of surgical hemorrhage: red cell concentrates, colloids and crystalloids. Bibl. Haematol., 1980; 46: 147.
Brugnara, C, Churchill, H. Plasma and component therapy. In Loscalzo, J., Schafer, A. I., eds., Thrombosis and Hemorrhage. Baltimore, MD: Williams and Wilkins; 1998: pp. 1135–62.
Contreras, M., Ala, F. A., Greaves, M., et al. Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus. Med., 1992; 2: 57–63.
Miller, R. D., Robbins, T. O., Tong, M. J., et al. Coagulation defects associated with massive blood transfusions. Ann. Surg., 1971; 174: 794–801.
Counts, R. B., Haisch, C., Simon, T. L., et al. Hemostasis in massively transfused trauma patients. Ann. Surg., 1979; 190: 91–9.
Ciavarella, D., Reed, R. L., Counts, R. B., et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br. J. Haematol., 1987; 67: 365–8.
Bick, R. L. Disseminated intravascular coagulation. In Bick, R. L., ed., Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice, 3rd edn. Philadelphia, PA: Lippincott, Williams and Wilkins; 2002: pp. 139–64.
Baker, W. F. JrClinical aspects of disseminated intravascular coagulation: a clinician's point of view. Semin. Thromb. Hemost., 1988; 15: 1–57.
Al-Mondhiry, H.Disseminated intravascular coagulation: experience in a major cancer center. Thromb. Diath. Haemorrh., 1975; 34: 181.
Leung, LLK. Hemorrhagic disorders. In Dale, D. C., Federman, D. D., eds., ACP Medicine. New York, NY: WebMD Inc.; 2004: 5, XIII, pp. 1–22.
Kushner, J. P. Normochromic normocytic anemia. In Wyngaarden, J. B., Smith, L. H., eds., Cecil Textbook of Medicine. 18th edn. Philadelphia, PA: W. B. Saunders; 1988: pp. 890–2.
Baker Jr, W. F. Clinical evaluation of the patient with anemia. In Bick, R. L., ed., Hematology: Clinical and Laboratory Practice. St. Louis, MD: Mosby; 1993: pp. 203–29.
Bunn, H. F., Federici, A. B., Serchia, G. Anemia. In Wilson, J. D., Braunwald, E., Isselbacher, K. J., et al. eds., Harrison's Principles of Internal Medicine. 12th edn. New York, NY: McGraw-Hill, Inc.; 1991: pp. 344–8.
Manucci, P. M., et al. Hemostasis testing during massive blood replacement. Vox Sang, 1982; 42: 113.
Noe, D. A., Graham, S. M., Luff, R., et al. Platelet counts during rapid massive transfusion. Transfusion, 1982; 22: 392.
Kopec, M., Wegrzynowiczy, Z., Budzynski, A., et al. Interaction of fibrinogen degradation products with platelets. Exp. Biol. Med., 1968; 3: 73.
Ono, S., Mochizuki, H., Tamakuma, S.A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation. Am. J. Surg., 1996; 171: 409.
Harker, L. A., Malpass, T. W., Branson, H. E., et al. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. Blood, 1980; 56: 824.
Ness, P. M., Perkins, H. A.Cryoprecipitate as a reliable source of fibrinogen replacement. JAMA, 1979; 241: 1690–1.
Bouwmeester, F. W., Jonkhoff, A. R., Verheijen, R. H., et al. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet. Gynecol., 2003; 101(6): 1174–6.
Boehlen, F., Morales, M. A., Fontana, P., et al. Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature. Br. J. Obstet. Gynaecol., 2004; 111(3): 284–7.
Segal, S., Shemesh, I. Y., Blumenthal, R., et al. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch. Gynecol. Obstet., 2003; 268(4): 266–7.
Martinowitz, U., Luboschitz, J., Lubetsky, A., et al. New approach for the management of coagulation at the site of injury by recombinant activated factor VII (rVIIa). Blood, 2001; 98: 827–8.
Moscardo, F., Perez, F., Rubia, J., et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br. J. Haematol., 2001; 114(1): 174–6.
Daro, A. F., Gollin, H. A., Lavieri, V.Management of postpartum hemorrhage by prolonged administration of oxytocics. Am. J. Obstet. Gynecol., 1952; 64: 1163–4.
Abdel-Aleem, H., El Nashar, I., Abdel-Aleem, A.Management of severe postpartum hemorrhage with misoprostol. Int. J. Gynaecol. Obstet., 1998; 92: 212–14.
Kupferminc, M. J., Gull, I., Bar-Am, A., et al. Intrauterine irrigation with prostaglandin F2-alpha for management of severe postpartum hemorrhage. Acta Obstet. Gynecol. Scand., 1998; 77: 548–50.
Peyser, M. R., Kupferminc, M.Management of severe post partum hemorrhage by intrauterine irrigation with prostaglandin E2. Am. J. Obstet. Gynecol., 1990; 162: 694–6.
Mousa, H. A., McKinley, C., Thong, J.Acute post-partum myocardial infarction after ergometrine administration in a woman with familial hypercholesterolemia. Br. J. Obstet. Gynaecol., 2000; 107: 939–40.
Chen, F. G., Koh, K. F., Chong, Y. S.Cardiac arrest associated with sulprostone use during cesarean section. Anaesth. Intensive Care, 1998; 26: 298–301.
Feinstein, D. I., Marder, V. I., Colman, R. W. Consumptive thrombohemorrhagic disorders. In Colman, R. W., Hirsh, J., Marder, V. J., eds., Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott, Williams and Wilkins; 2001: pp. 1197–233.
Hedner, U., Hirsh, J., Marder, V. J. Therapy with antifibrinolytic agents. In Colman, R. W., Hirsh, J., Marder, V. I., et al. eds., Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadeplhia, PA: Lippincott, Williams and Wilkins; 2001: pp. 797–813.
Scwartz, B. S., Williams, E. C., Conlan, G., et al. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibtior deficiency. Ann. Intern. Med., 1986; 105: 873.
Gai, M-Y., Wu, L-F., Su, Q-F., et al. Clinical observation of blood loss reduced by tranexamic acid during and after cesarean section: a multi-center, randomized trial. Eur. J. Obstet. Gynecol. Reprod. Biol., 2000; 112: 154–7.
Avvisati, G., ten Cate, J. W., Buller, H. R., et al. Tranexamic acid for control of hemorrhage in acute promyelocytic leukemia. Lancet, 1989; 2(8655): 122–4.
Dunn, C. J., Goa, K. L.Tranexamic acid: a review of its use in surgery and other indications. Drugs, 1999; 57(1005).
Peters, D. C., Noble, S.Aprotonin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs, 1999; 57: 23.
As, A. K., Hagen, P., Webb, J. B.Tranexamic acid in the management of postpartum haemorrhage. Br. J. Obstet. Gynaecol., 1996; 103(12): 1250–1.
Lurie, S., Appelman, Z., Katz, Z.Subendometrial vasopressin to control intractable placental bleeding. Lancet, 1997; 349: 698.
Domsky, M. F., Wilson, R. F.Hemodynamic resuscitation. Crit. Care Clin., 1993; 10: 715–26.
Abboud, F. M. Shock. In Wyngaarden, J. B., Smith, L. H., eds., Cecil Textbook of Medicine. Philadelphia, PA: W. B. Saunders Co.; 1988: pp. 236–50.
Kale, I. T., Kuzu, M. A., Berkem, H., et al. The presence of hemorrhagic shock increases the rate of bacterial translocation in blunt abdominal trauma. J. Trauma, 1998; 44: 171–4.
Astiz, M. E., Rackow, E. C.Assessing perfusion failure circulatory shock. Crit. Care. Clin., 1993; 9: 299–312.
Gynecologists ACoOa. Invasive Hemodynamic Monitoring in Obstetrics and Gynecology. Washington, D.C.: ACOG; 1992.
Conference Pacc. Pulmonary artery consensus conference: consensus statement. Crit. Care. Med., 1997; 25(6): 910–25.
Ware, L. B., Matthay, M. A.The acute respiratory distress syndrome. N. Engl. J. Med., 2000; 341: 1334.
Staton, G. W. Pulmonary edema. In Dale, D. C., Federman, D. D., eds., ACP Medicine. New York, NY: WebMD Inc.; 2004: 14:X:1–20.
Duane, P. G., Colice, G. L.Impact of noninvasive studies to distinguish volume overload from ARDS in acutely ill patients with pulmonary edema: analysis of the medical literature from 1966–1998. Chest, 2000; 118: 1709.
Hayashi, M., Mori, Y., Nogami, K., et al. A hypothesis to explain the occurrence of inner myometrial laceration causing massive postpartum hemorrhage. Acta Obstet. Gynecol. Scand., 2000; 79(2): 99–106.
Jones III, H. W., Rock Jr, W. A. Control of pelvic hemorrhage. In Rock, J. A., Jones, H. W. III, eds., Te Linde's Operative Gynecology. Philadelphia, PA: Lippincott, Williams and Wilkins: pp. 413–46.
Rosch, C., Dotter, C. T., Brown, M. J.Selective arterial embolization. Radiology, 1972; 102: 303–6.
Brown, B. J., Heaston, D. K., Poulson, A. M., et al. Uncontrollable postpartum bldeeding: a new approach to hemostasis through angiographic embolization. Obstet. Gynecol., 1979; 54: 361–5.
Mitty, H., Sterling, K., Alvarez, M., et al. Obstetric haemorrhage: prophylactic and emergency arterial catheterization and embolotherapy. Radiology, 1996; 188: 183–7.
Merland, J. J., Houdart, E., Herbreteau, D., et al. Place of emergency arterial embolization in obstetric hemorrhage about 16 personal cases. Eur. J. Obstet. Gynecol. Reprod. Biol., 1996; 65: 141–3.
Collins, C. D., Jackson, J. E.Pelvic arterial embolization following hysterectomy and bilateral internal iliac artery ligation for intractable post partum hemorrhage. Clin. Radiol., 1995; 50: 710–3.
Reyal, F., Pelage, J. P., Rossignol, M., et al. Interventional radiology in managing post-partum hemorrhage. Presse Med., 2002; 31(20): 939–44.
Yamashita, Y., Harada, M., Yamamato, H., et al. Transcatheter arterial embolization of obstetric and gynaecological bleeding; efficacy and clinical outcome. Br. J. Radiol., 1994; 67: 530–4.
Oei, S. G., Kho, S. N., ten Broeke, E. D., et al. Arterial balloon occlusion of the hypogastric arteries: a life-saving procedure for severe obstetric hemorrhage. Am. J. Obstet. Gynecol., 2001; 185(5): 1255–6.
Descargues, G., Douvrin, F., Gravier, A., et al. False aneurysm of the uterine pedicle: an uncommon cause of post-partum haemorrhage after caesarean section treated with selective arterial embolization. Eur. J. Obstet. Gynecol. Reprod. Biol., 2001; 97(1): 26–9.
Murakami, R., Ichikawa, T., Kumazaki, T., et al. Transcatheter arterial embolization for postpartum massive hemorrhage: a case report. Clin. Imaging, 2000; 24(6): 368–70.
Pelage, J. P., Dref, O., Jacob, D., et al. Selective arterial embolization of the uterine arteries in the management of intractable post-partum hemorrhage. Acta Obstet. Gynecol. Scand., 1999; 78(8): 698–703.
Pelage, J. P., Soyer, P., Repiquet, D., et al. Secondary postpartum hemorrhage: treatment with selective arterial embolization. Radiology, 1999; 212(2): 385–9.
Corr, P.Arterial embolization for haemorrhage in the obstetric patient. Best Pract. Res. Clin. Obstet. Gynaecol., 2001; 15(4): 557–61.
Badawy, S. Z., Etman, A., Singh, M., et al. Uterine artery embolization: the role in obstetrics and gynecology. Clin. Imaging, 2001; 25(4): 288–95.
Tourne, G., Collet, F., Seffert, P., et al. Place of embolization of the uterine arteries in the management of post-partum haemorrhage: a study of 12 cases. Eur. J. Obstet. Gynecol. Reprod. Biol., 2003; 110(1): 29–34.
Hong, T. M., Tseng, H. S., Lee, R. C., et al. Uterine artery embolization: an effective treatment for intractable obstetric haemorrhage. Clin. Radiol., 2004; 59(1): 96–101.
Salomon, L. J., deTayrac, R., Castaigne-Meary, V., et al. Fertility and pregnancy outcome following pelvic arterial embolization for severe post-partum haemorrhage. A cohort study. Hum. Reprod., 2003; 18(4): 849–52.
Ornan, D., White, R., Pollak, J., et al. Pelvic embolization for intractable postpartum hemorrhage: long-term follow-up and implications for fertility. Obstet. Gynecol., 2003; 102(5 Pt 1): 904–10.
Cordonnier, C., Ha-Vien, D. E., Depret, S., et al. Foetal growth restriction in the next pregnancy after uterine artery embolisation for post-partum haemorrhage. Eur. J. Obstet. Gynecol. Reprod. Biol., 2002; 103(2): 183–4.
Ledee, N., Ville, Y., Musset, D., et al. Management in intractable obstetric haemorrhage: an audit study on 61 cases. Eur. J. Obstet. Gynecol. Reprod. Biol., 2001; 94(2): 189–96.
Marcovici, I., Scoccia, B.Postpartum hemorrhage and intrauterine balloon tamponade. A report of three cases. J. Reprod. Med., 1999; 44(2): 122–6.
Katesmark, M., Brown, R., Raju, K. S.Successful use of a Sengstaken–Blakemore tube to control massive postpartum hemorrhage. Br. J. Obstet. Gynaecol., 1994; 101: 259–60.
Johanson, R., Kumar, M., Obhrai, M., et al. Management of massive postpartum haemorrhage: use of a hydrostatic balloon catheter to avoid laparotomy. Br. J. Obstet. Gynaecol., 2001; 108(4): 420–2.
Tamizian, O., Arulkumaran, S.The surgical management of postpartum haemorrhage. Curr. Opin. Obstet. Gynecol., 2001; 13(2): 127–31.
Pinborg, A., Bodker, B., Hogdall, C.Postpartum hematoma and vaginal packing with a blood pressure cuff. Acta Obstet. Gynecol. Scand., 2000; 79(10): 887–9.
Hensleigh, P. A.Anti-shock garment provides resuscitation and haemostasis for obstetric haemorrhage. Br. J. Obstet. Gynaecol., 2002; 109(12): 1377–84.
Maier, R. C.Control of postpartum hemorrhage with uterine packing. Am. J. Obstet. Gynecol., 1993; 169(2 Pt 1): 317–21; discussion, 21–3.
Condous, G. S., Arulkumaran, S., Symonds, I., et al. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet. Gynecol., 2003; 101(4): 767–72.
Bakri, Y. N.Balloon device for control of obstetrical bleeding. Eur. J. Obstet. Gynecol. Reprod. Biol., 1999; 86: S84.
Bakri, Y. N., Amri, A., Abdul, , Jabbar, F.Tamponade-balloon for obstetrical bleeding. Int. J. Gynaecol. Obstet., 2001; 74(2): 139–42.
Waters, E. G.Surgical management of postpartum hemorrhage with particular reference to ligation of uterine arteries. Am. J. Obstet. Gynecol., 1952; 64: 1143–8.
O'Leary, J. A.Uterine artery ligation in the control of postcesarean hemorrhage. J. Reprod. Med., 1995; 40(3): 189–93.
AbdRabbo, S. A.Stepwise uterine devascularization: a novel technique for management of uncontrollable postpartum hemorrhage with preservation of the uterus. Am. J. Obstet. Gynecol., 1994; 171: 694–700.
Burchell, R. C.Internal iliac artery ligation: Hemodynamics. Obstet. Gynecol., 1964; 24: 737–9.
Clark, S. L., Phelan, J. P., Yeh, S. Y., et al. Hypogastric artery ligation for obstetric hemorrhage. Obstet. Gynecol., 1985; 66: 353–6.
Nizard, J., Barrinque, L., Frydman, R., et al. Fertility and pregnancy outcomes following hypogastric artery ligation for severe post-partum haemorrhage. Hum. Reprod., 2003; 18(4): 844–8.
B-Lynch, C., Coker, A., Lawal, A. H., et al. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br. J. Obstet. Gynaecol., 1997; 104(3): 372–5.
Pal, M., Biswas, A. K., Bhattacharya, S. M.B-Lynch Brace Suturing in primary post-partum hemorrhage during cesarean section. J. Obstet. Gynaecol. Res., 2003; 29(5): 317–20.
Dacus, J. V., Busowski, M. T., Busowski, J. D., et al. Surgical treatment of uterine atony employing the B-Lynch technique. J. Matern. Fetal Med., 2000; 9(3): 194–6.
Ferguson, J. E., Bourgeois, F. J., Underwood, P. B.B-Lynch suture for postpartum hemorrhage. Obstet. Gynecol., 2000; 95(6 Pt 2): 1020–2.
Cho, J. H., Jun, H. S., Lee, C. N.Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstet. Gynecol., 2000; 96(1): 129–31.
Zelop, C. M., Harlow, B. L., Frigoletto, F. D. Jr, et al. Emergency peripartum hysterectomy. Am. J. Obstet. Gynecol., 1993; 168: 1443–8.
Okogbenin, S. A., Gharoro, E. P., Otoide, V. O., et al. Obstetric hysterectomy: fifteen years' experience in a Nigerian tertiary centre. J. Obstet. Gynaecol., 2003; 23(4): 356–9.
Clark, S. L., Yeh, S. Y., Phelan, J. P., et al. Emergency hysterectomy for obstetric hemorrhage. Obstet. Gynecol., 1984; 64(3): 376–80.
Chanrachakul, B., Chaturachinda, K., Phuapradit, W., et al. Cesarean and postpartum hysterectomy. Intl. J. Gynaecol. Obstet., 1996; 54: 109–13.
Wenham, J., Matijevic, R.Post-partum hysterectomies: revisited. J. Perinat. Med., 2001; 29(3): 260–5.
Seckin, N. C., Inegol, I., Turhan, N. O., et al. Life-threatening second trimester disseminated intravascular coagulopathy with protein S deficiency. Clin. Appl. Thromb. Hemost., 2004; 10: 289–91.
Cicala, C., Cirino, G.Linkage between inflammation and coagulation: An update on the molecular basis of the crosstalk. Life Sci., 1998; 62: 1817–24.
Muller-Berghaus, G.Pathophysiological and biochemical events in disseminated intravascular coagulation: dysregulation of procoagulant and anticoagulant pathways. Semin. Thromb. Hemost., 1989; 15: 58–87.
Verstraete, M., Vermylen, C., Vermylen, J.Excessive consumption of blood coagulation components as a cause hemorrhagic diathesis. Am. J. Med., 1965; 35: 899–905.
Rodriguez-Erdmann, F.Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies). N. Engl. J. Med., 1965; 273: 1370–8.
Boer, K., ten Cate, J. W., Sturk, A., et al. Enhanced thrombin generation in normal and hypertensive pregnancy. Am. J. Obstet. Gynecol., 1989; 160: 95–100.
Weiner, C. P.Preeclampsia-eclampsia syndrome and coagulation. Clin. Perinatol., 1991; 18: 713–26.
Weiner, C. P.The obstetric patient and disseminated intravascular coagulation. Clin. Perinatol., 1986; 13: 705–17.
Pritchard, J. A., Brekken, A. L.Clinical and laboratory studies on severe abruptio placentae. Am. J. Obstet. Gynecol., 1967; 97: 681.
Bick, R. L.Disseminated intravascular coagulation and related syndromes: a clinical review. Semin. Thromb. Hemost., 1988; 14: 299–338.
Martin, J. N. J., Stedman, C. M.Imitators of preeclampsia and HELLP syndrome. Obstet. Gynecol. Clin. North Am., 1991; 18: 181–98.
McDougall, R. J., Duke, C. J.Amniotic fluid embolism syndrome. Case report and review. Anaesthesia Intensive Care, 1995; 23: 735–40.
Feinstein, D. I.Treatment of disseminated intravascular coagulation. Semin. Thromb. Hemost., 1988; 14(4): 351–62.
Lewis, B. E., Wallis, D. E., Berkowitz, S. D., et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation, 2001; 103: 1838.
Munoz, M. C., Montes, R., Hermida, J., et al. Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits. Br. J. Haematol., 1999; 105: 117–22.
ten Cate, H., Nurmohamed, M. T., ten Cate, J. W.Developments in antithrombotic therapy: state of the art anno 1996. Pharmacology World Science 1996; 18: 195–203.
Bick, R. L. Heparin and low-molecular-weight heparins. In Bick, R. L., ed., Disorders of Thrombosis and Hemostasis. Philadelphia, PA: Lippincott, Williams and Wilkins 1992: pp. 359–77.
Jochum, M.Influence of high-dose antithrombin concentrate therapy on the release of cellular proteases, cytokines and soluble molecules in acute inflammation. Semin. Hematol., 1995; 32: 14.
Fourier, F., Chopin, C., Huart, J. J., et al. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest, 1993; 104: 882.
Laursen, B., Mortensen, J. Z., Frost, L., et al. DIC in hepatic failure treated with antithrombin III. Thromb. Res., 1981; 22: 701.
Eisele, B., Lamy, M.Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure. Semin. Thromb. Hemost., 1998; 24: 71.
Okajima, K., Uchida, M.The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin. Thromb. Hemost., 1998; 24: 27.
Baluhut, B., Kramar, H., Vinazzer, H., et al. Substitution of ATIII in shock and DIC: a randomized study. Thromb. Res., 1985; 39: 81.
Kries, R., Stannigel, H., Gobel, U.Anticoagulant therapy by continuous heparin-ATIII infusion in newborns with DIC. Eur. J. Pediatr., 1985; 144: 191.
Bernard, G. R., Vincent, J. L., Latere, P. F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med., 2001; 344: 699.
Smith, O. P.Protein-C concentrate for meningococcal purpura fulminans. Lancet, 1998; 351: 986.
Fijinvandraat, K., Derkx, B., Peters, M., et al. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality. Thromb. Haemost., 1995; 73: 15.
Shoemaker, W. C. Circulatory pathophysiology of ARDS and its fluid management. In Textbook of Critical Care. Philadelphia, PA: W. B. Saunders Company; 1995: p. 312.
Urden, L. D., Stacy, K. M., Lough, M. E., Shock. In Thelan's Critical Care Nursing: Diagnosis and Management. St. Louis, MO: Mosby; 2002: p. 931.
Abrams, J., et al. Vassopressors used in shock. In Drug: Facts and Comparisons, 1999 edn; Philadelphia, PA: Lippincott, Williams, and Wilkins; 1999: pp. 883–917.
Uterine Artery Ligation. 2004. (Accessed November 31, 2004, at www.utodol.com/application/ image.asp?).
B-Lynch Suture. 2000. (Accessed November 30, 2004, at www.utdol.com/application/image.asp?).